Skip to content

GDPoster

Key China Coronavirus Hospital Says HIV Drug Beneficial to Patients

    Chinese doctors at the primary hospital treating severe coronavirus patients in the city of Wuhan said they have been using the HIV drug Kaletra/Aluvia  since January and believe it is beneficial, despite a previous study that it was ineffective. They have been prescribing Kaletra, an off-patent version of lopinavir/ritonavir produced by AbbVie, as well as… Read More »Key China Coronavirus Hospital Says HIV Drug Beneficial to Patients

    Best Time To Sleep

        We’ve been fascinated by the topic of sleep recently, mainly because most of us agree that we either don’t get enough of it or can’t seem to do it. There’s no doubt sleep is an essential part of your life. Without it, you’re left drowsy, exhausted, and unable to work at your best. In… Read More »Best Time To Sleep

      ‘Don’t Target Doctors’: Indian Medics Say Coronavirus Critics Being Muzzled

        Indian authorities are facing growing complaints from doctors who say their criticism of the response to the coronavirus outbreak and a lack of protective gear is being muzzled. The Resident Doctor’s Association of New Delhi’s All India Institute of Medical Sciences, which represents 2,500 doctors, wrote on Monday to Prime Minister Narendra Modi complaining about… Read More »‘Don’t Target Doctors’: Indian Medics Say Coronavirus Critics Being Muzzled

        Mylan Waives Exclusive U.S. Distribution Rights for Potential COVID-19 Therapy

          U.S. drugmaker Mylan NV said it had waived its exclusive U.S. distribution rights to its generic version of HIV treatment Kaletra, which is currently being tested against the coronavirus. The move would make other drugmakers eligible to seek U.S. approval for their generic versions of the drug and boost supply, which would help in case… Read More »Mylan Waives Exclusive U.S. Distribution Rights for Potential COVID-19 Therapy

          Risk Factors for Death From COVID-19 Identified in Wuhan Patients

            Patients who did not survive hospitalization for COVID-19 in Wuhan were more likely to be older, have comorbidities, and elevated D-dimer, according to the first study to examine risk factors associated with death among adults hospitalized with COVID-19. “Older age, showing signs of sepsis on admission, underlying diseases like high blood pressure and diabetes, and the prolonged use… Read More »Risk Factors for Death From COVID-19 Identified in Wuhan Patients

            FDA Adds Boxed Warning to Montelukast Over Mental Health Risks

              The US Food and Drug Administration (FDA) is strengthening existing warnings about serious behavior and mood-related changes with montelukast (Singulair), which is used to treat asthma and allergy. The agency will add a boxed warning to montelukast advising healthcare providers to avoid prescribing montelukast for patients with mild symptoms, particularly those with allergic rhinitis, according… Read More »FDA Adds Boxed Warning to Montelukast Over Mental Health Risks